KRT88P and infection: HBV reactivation has been observed in inactive carriers (HBsAg-positive) or patients with resolved infection (HBsAg-negative and anti-HBc- and/or anti-HBs-positive) who have undergone immunosuppressive therapy and/or chemotherapy.